TGA cautions against over-buying medicines
The TGA’s response to reports of local-level out-of-stocks in some pharmacies due to over-buying
Published
Related content
-
TGA response to coronavirus (COVID-19)
Information updated following the cessation of the Therapeutic Goods (Medical Devices—Accredited Pathology Laboratories) (COVID-19 Emergency) Exemption 2020 -
Limited Ozempic supplies to commence distribution in Australia
Supplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time. -
TGA to permit conditional substitution to ease serious shortages
In response to the COVID-19 pandemic, the TGA is implementing Serious Shortage Medicine Substitution Notices
This webpage on the TGA website was printed on 18 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/news/media-releases/tga-cautions-against-over-buying-medicines